Market Cap

Viridian Therapeutics, Inc. Market Capitalization:

$786.3 Million

USD as of July 1, 2024

business Viridian Therapeutics, Inc. Company Profile

Viridian Therapeutics, Inc. Main Stock Listing

NASDAQ: VRDN

Market Capitalization History of Viridian Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Viridian Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $1.12 B -26.22%
Jan. 1, 2023 $1.51 B 86.97%
Jan. 1, 2022 $809.0 M 12.79%
Jan. 1, 2021 $717.2 M -32.11%
Jan. 1, 2020 $1.06 B -38.81%
Jan. 1, 2019 $1.73 B -61.87%
Jan. 1, 2018 $4.53 B -17.31%
Jan. 1, 2017 $5.48 B 9.94%
Jan. 1, 2016 $4.98 B -79.73%
Jan. 1, 2015 $24.58 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +177.66%

$10,000 in August 2023 would now be $27,766 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Viridian Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Viridian Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: VRDN

Stock: FSX: 1S1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.